# US Fluoroscopy Mobile C-Arms Market > US Fluoroscopy Mobile C-Arms Market Research Report: By Device Type (Fluoroscopy Systems, Mobile C-Arms), By Application (Gastrointestinal, Orthopedics, Neurology, Others) and By End User (Hospital, Clinics, Others) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 8.7% - **2024:** $ 0.63 Million - **2025:** $ 0.68 Million - **2035:** $ 1.58 Million - **Key Players:** GE Healthcare (US), Siemens Healthineers (DE), Philips Healthcare (NL), Canon Medical Systems (JP), Fujifilm Holdings (JP), Hitachi Medical Systems (JP), Hologic (US), Agfa HealthCare (BE), Esaote (IT) **Report ID:** MRFR/HC/11374-HCR · **Pages:** 100 · **Author:** Rahul Gotadki & Garvit Vyas · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-fluoroscopy-mobile-c-arms-market-12899 --- ## Market Summary ## **US Fluoroscopy Mobile C-Arms Market Overview** **As per MRFR analysis, the US Fluoroscopy Mobile C-Arms Market Size was estimated at 680.95 (USD Million) in 2023. The US Fluoroscopy Mobile C-Arms Market Industry is expected to grow from 750(USD Million) in 2024 to 1,300 (USD Million) by 2035. The US Fluoroscopy Mobile C-Arms Market CAGR (growth rate) is expected to be around 5.128% during the forecast period (2025 - 2035).** ### **Key Market Trends** The US fluoroscopy mobile C-arms market is experiencing notable trends driven by advancements in medical imaging technology and growing demand for minimally invasive procedures. One key market driver is the increasing prevalence of chronic diseases that necessitate detailed imaging for accurate diagnosis and treatment. Hospitals and surgical centers are investing in mobile C-arms to enhance operational efficiency and provide better patient outcomes. The mobility of these devices allows for flexibility in various clinical settings, enabling healthcare providers to perform procedures in different locations within facilities, which is especially important in high-volume hospitals. Recent trends also highlight the integration of advanced imaging capabilities, such as 3D imaging and improved radiation dose management, into mobile C-arms. As patient safety becomes a priority, manufacturers are focusing on developing devices with lower radiation exposure without compromising image quality. Furthermore, the rising adoption of telemedicine and remote consultation is pushing healthcare facilities to seek portable imaging solutions that can be used in outpatient and home care settings. There are significant opportunities for innovation in this market, such as the incorporation of artificial intelligence to enhance imaging analysis and workflow optimization. Additionally, the shift towards value-based care models creates a demand for efficient imaging solutions that can help reduce costs while improving patient care. As healthcare providers in the US look for ways to streamline operations and improve service delivery, mobile C-arms are positioned to play a vital role in meeting these evolving healthcare needs. Overall, the US [fluoroscopy mobile C-arms](../../../reports/fluoroscopy-mobile-c-arms-market-7717) market is likely to continue expanding, shaped by technological advancements and the persisting trend towards patient-centered care. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **US Fluoroscopy Mobile C-Arms Market Drivers** ### **Increasing Adoption of Minimally Invasive Surgeries** The US Fluoroscopy Mobile C-Arms Market Industry is significantly driven by the rising trend of minimally invasive surgeries, as they offer reduced recovery time and lower risk of complications. According to the American College of Surgeons, there has been a 20% increase in the number of minimally invasive procedures conducted over the past decade in the United States. This trend is supported by organizations like Medtronic and Stryker, which are actively developing advanced C-Arm technologies tailored for such procedures. As healthcare facilities adopt these innovative solutions, the need for portable imaging tools like mobile C-Arms surges, further propelling the market growth in the US. Additionally, the Centers for Medicare & Medicaid Services has recognized the efficacy of these procedures by providing favorable reimbursement policies, enhancing the accessibility and affordability of advanced surgical interventions for patients. ### **Technological Advancements in Imaging Devices** Innovations in imaging technology are a major driver for the US Fluoroscopy Mobile C-Arms Market Industry. The integration of features such as enhanced imaging resolutions and advanced user interfaces drastically improves the efficiency and reliability of medical imaging. For instance, GE Healthcare has introduced upgraded mobile C-Arms equipped with real-time imaging capabilities, which offer clearer and faster diagnostic results. Furthermore, the FDA has reported an increase in the number of approvals for advanced imaging systems, which indicates a healthy innovation landscape that supports growth in this market. These technological advancements enhance procedural outcomes and consequently encourage healthcare facilities across the United States to invest in mobile C-Arms, contributing to the market's expansion. ### **Rising Incidence of Chronic Diseases** The growing prevalence of chronic diseases such as cardiovascular diseases, obesity, and orthopedic issues is driving demand in the US Fluoroscopy Mobile C-Arms Market Industry. Recent reports indicate that approximately 60% of adults in the US live with at least one chronic condition, as per the Centers for Disease Control and Prevention. This increasing patient demographic necessitates the efficient use of mobile imaging solutions for diagnosis and treatment, thus fostering demand for C-Arms. Organizations like the American Heart Association have reported a notable rise in the different cardiovascular procedures performed, thereby boosting the utilization of fluoroscopy in diagnostics and interventions. Consequently, healthcare facilities are likely to invest more in mobile C-Arms to cater to the needs of an aging population burdened with chronic illnesses. ## **US Fluoroscopy Mobile C-Arms Market Segment Insights** ### **Fluoroscopy Mobile C-Arms Market Device Type Insights** The US Fluoroscopy Mobile C-Arms Market has shown significant relevance in the medical imaging landscape, particularly through its division into Device Types such as Fluoroscopy Systems and Mobile C-Arms. Fluoroscopy Systems are crucial for providing real-time imaging, which is vital for a variety of diagnostic and surgical procedures. Their ability to visualize the movement of internal organs helps in achieving precise outcomes in interventions. The demand for Fluoroscopy Systems has been bolstered by advancements in imaging technology and increased preference for minimally invasive surgeries across hospitals and clinics in the U.S. Mobile C-Arms, on the other hand, play a pivotal role in enhancing the versatility and efficiency of imaging in operating rooms. The mobility of these devices allows them to be used in various settings, from operating theaters to outpatient facilities. This adaptability meets the evolving needs of physicians seeking to facilitate seamless imaging during critical interventions. The convenience of a Mobile C-Arm also leads to a reduced footprint and improved workflow within medical facilities, catering to a growing emphasis on operational efficiency. As these devices become integral to the surgical team’s toolkit, they contribute significantly to procedural success rates, thereby influencing physician and patient satisfaction. The expansion of high-quality healthcare in the U.S. suggests a growing appreciation for the innovations in the US Fluoroscopy Mobile C-Arms Market. Technological advancements, such as improved imaging quality, enhanced mobility features, and innovation in user interfaces, further reinforce the demand. The growing prevalence of chronic diseases and the resultant increase in surgical procedures also underscore the market's potential. Challenges such as the cost of equipment and the need for skilled professionals to operate advanced fluoroscopy equipment cannot be overlooked, as they have a substantial impact on market dynamics. However, the opportunities presented by ongoing Research and Development efforts and increasing healthcare funding offer a pathway for future growth. As healthcare facilities continue to invest in the latest imaging technology, the importance of both Fluoroscopy Systems and Mobile C-Arms in the US Fluoroscopy Mobile C-Arms Market remains evident, ensuring their long-term prominence in improving patient outcomes and operational effectiveness. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Fluoroscopy Mobile C-Arms Market Application Insights** The US Fluoroscopy Mobile C-Arms Market is significantly influenced by its Application segmentation, which includes categories such as Gastrointestinal, Orthopedics, Neurology, and others. The growth of the market can be attributed to the increasing demand for minimally invasive procedures, leading to advancements in mobile C-arm technology that enhances visualization and diagnostic capabilities. The Orthopedics category plays a pivotal role, as these devices are often utilized in surgical procedures and trauma care, streamlining operations and improving patient outcomes. Similarly, the Gastrointestinal segment is gaining traction due to rising incidences of gastrointestinal diseases, necessitating effective imaging solutions in diagnostic and therapeutic settings. Neurology applications utilize mobile C-arms for precise imaging during complex procedures, allowing for better assessment and treatment strategies. Meanwhile, "Others" encompass various applications that support a wide range of surgical and diagnostic needs, showcasing the adaptability of mobile C-arms in diverse healthcare scenarios. Overall, the US Fluoroscopy Mobile C-Arms Market benefits from technological innovations and the growing trend of outpatient procedures, positioning it for continued growth in various application segments. ### **Fluoroscopy Mobile C-Arms Market End User Insights** The US Fluoroscopy Mobile C-Arms Market is significantly shaped by its End User segment, which includes Hospitals, Clinics, and Other facilities. Within this market, Hospitals are major participants due to their extensive infrastructure, comprehensive medical services, and the increasing demand for minimally invasive surgical procedures that utilize fluoroscopy. The preference for mobile C-Arms in these settings is evident as they allow for mobility and flexibility in surgical suites and emergency departments, enhancing overall patient care efficiency. Clinics also play a vital role in the market by catering to specialized procedures, which increases the accessibility of advanced imaging technology to a broader patient demographic. Other facilities encompass outpatient surgical centers and urgent care clinics, reflecting a growing trend of decentralized healthcare services, thereby broadening the reach of fluoroscopy technologies. Factors such as an aging population, a rise in chronic diseases, and technological advancements are anticipated to drive the market growth across these segments, creating opportunities for innovative medical solutions and improved patient outcomes. Overall, the segmentation within the US Fluoroscopy Mobile C-Arms Market illustrates diverse demands across different healthcare settings, each contributing uniquely to the market landscape. ## **US Fluoroscopy Mobile C-Arms Market Key Players and Competitive Insights** The US Fluoroscopy Mobile C-Arms Market is characterized by intense competition among numerous players striving to capture market share through innovation, advanced technology, and customer-centric solutions. The market dynamics are influenced by the rising demand for minimally invasive surgical procedures, which necessitate the use of high-quality imaging devices that ensure precision and adaptability. The competitive landscape is marked by ongoing product development, partnerships, and strategic acquisitions that enhance the capabilities and performance of mobile C-arms. Companies are also increasingly focusing on user-friendly designs and enhanced portability that cater to the evolving needs of healthcare providers, further intensifying the competition within this sector. The emphasis on interoperability with existing hospital systems and the incorporation of advanced imaging technologies are key factors driving competitive strategies. Hologic has established a strong presence in the US Fluoroscopy Mobile C-Arms Market through its commitment to developing cutting-edge imaging technology that enhances patient care. The company's strengths lie in its expertise in diagnostic and surgical imaging solutions, which are recognized for their precision and reliability. Hologic's mobile C-arms are designed to facilitate a wide range of surgical applications, delivering high-quality imaging in various clinical settings. Additionally, Hologic's robust distribution network and customer support services further enhance its market position, allowing it to maintain strong relationships with healthcare providers and hospitals. The company focuses on continuous innovation, ensuring that it stays ahead of competitors in providing advanced solutions tailored to contemporary medical practices. Ziehm Imaging is a notable player in the US Fluoroscopy Mobile C-Arms Market, well-regarded for its advanced imaging solutions tailored for surgical applications. The company offers a range of key products/services, including mobile C-arms that provide high-definition imaging necessary for complex procedures. Ziehm Imaging's strengths are rooted in its emphasis on precision and user-friendly interfaces, thereby improving workflow efficiency for medical professionals. The company's commitment to research and development allows it to introduce innovative solutions that meet the evolving demands of the healthcare sector. Furthermore, Ziehm Imaging has gained traction in the US market through strategic partnerships and potential mergers and acquisitions that bolster its market reach and product offerings. These initiatives not only enhance Ziehm Imaging's presence but also position it as a competitive force within the industry focused on delivering exceptional imaging technologies that cater to the needs of healthcare providers. ### **Key Companies in the US Fluoroscopy Mobile C-Arms Market Include** ## **US Fluoroscopy Mobile C-Arms Market Industry Developments** The US Fluoroscopy Mobile C-Arms Market is witnessing significant developments, with advancements in technology and increasing demand for minimally invasive surgical procedures. Companies like Hologic and Siemens Healthineers are innovating with enhanced imaging capabilities to cater to the growing needs of healthcare institutions. In September 2023, GE Healthcare announced the launch of a new mobile C-arm designed for orthopedic surgeries, aiming to improve surgical accuracy and patient outcomes. There has also been notable interest in mergers and acquisitions; for instance, Fujifilm Holdings acquired a medical imaging firm in August 2023 to expand its fluroscopy portfolio, a move expected to enhance their market position. Current market growth is driven by an increase in outpatient procedures, evolving healthcare infrastructure, and a focus on patient-centric solutions. In light of these trends, companies like Varian Medical Systems and Canon Medical Systems are ramping up Research and Development to further solidify their presence in this lucrative market. Overall, the US Fluoroscopy Mobile C-Arms Market is experiencing dynamic changes that reflect broader trends in the healthcare industry. ## **US Fluoroscopy Mobile C-Arms Market Segmentation Insights** ### **Fluoroscopy Mobile C-Arms Market Device Type Outlook** ### **Fluoroscopy Mobile C-Arms Market Application Outlook** ### **Fluoroscopy Mobile C-Arms Market End User Outlook** - Hospital - Clinics - Others ## Market Drivers ### Rising Prevalence of Chronic Diseases The increasing incidence of chronic diseases such as cardiovascular disorders and orthopedic conditions is a primary driver for the fluoroscopy mobile-c-arms market. As these diseases necessitate frequent imaging for diagnosis and treatment, the demand for advanced imaging solutions rises. According to recent data, chronic diseases account for approximately 70% of all deaths in the US, highlighting the urgent need for effective diagnostic tools. Fluoroscopy mobile-c-arms provide real-time imaging, which is crucial for guiding minimally invasive procedures. This trend is expected to propel the market forward, as healthcare providers seek to enhance patient outcomes through improved imaging technologies. ### Growing Preference for Outpatient Procedures The shift towards outpatient procedures is a notable driver for the fluoroscopy mobile-c-arms market. As healthcare systems aim to reduce costs and improve patient convenience, there is a growing preference for procedures that can be performed outside of traditional hospital settings. Mobile C-arms facilitate this trend by providing high-quality imaging in outpatient facilities, enabling quicker patient turnover and reduced hospital stays. This shift is supported by data indicating that outpatient surgeries have increased by over 30% in recent years. Consequently, the fluoroscopy mobile-c-arms market is likely to benefit from this trend, as more healthcare providers adopt mobile imaging solutions to meet the demands of outpatient care. ### Technological Innovations in Imaging Systems Technological advancements in imaging systems are significantly influencing the fluoroscopy mobile-c-arms market. Innovations such as enhanced image quality, improved portability, and advanced software capabilities are making these systems more appealing to healthcare facilities. For instance, the integration of artificial intelligence and machine learning algorithms into imaging systems is streamlining workflows and improving diagnostic accuracy. The market for fluoroscopy mobile-c-arms is projected to grow at a CAGR of around 5% over the next few years, driven by these technological enhancements. As hospitals and clinics invest in state-of-the-art equipment, the demand for mobile C-arms is likely to increase, reflecting a shift towards more efficient healthcare delivery. ### Increased Investment in Healthcare Infrastructure Investment in healthcare infrastructure is a critical driver for the fluoroscopy mobile-c-arms market. As the US government and private sector stakeholders allocate funds to enhance healthcare facilities, the demand for advanced imaging technologies is expected to rise. Recent reports indicate that healthcare spending in the US is projected to reach $6 trillion by 2027, with a significant portion directed towards upgrading medical equipment. This influx of capital is likely to lead to increased procurement of fluoroscopy mobile-c-arms, as healthcare providers seek to modernize their imaging capabilities. The expansion of healthcare infrastructure is anticipated to create a favorable environment for the growth of the fluoroscopy mobile-c-arms market. ### Regulatory Support for Advanced Imaging Technologies Regulatory support for advanced imaging technologies plays a vital role in shaping the fluoroscopy mobile-c-arms market. The US Food and Drug Administration (FDA) has been actively promoting the adoption of innovative imaging solutions through streamlined approval processes and guidelines. This regulatory environment encourages manufacturers to invest in research and development, leading to the introduction of cutting-edge mobile C-arms. As a result, healthcare providers are more likely to adopt these technologies, knowing they meet stringent safety and efficacy standards. The positive regulatory landscape is expected to foster growth in the fluoroscopy mobile-c-arms market, as new products enter the market and enhance imaging capabilities. ## Future Outlook The [Fluoroscopy Mobile C-Arms Market](https://www.marketresearchfuture.com/reports/fluoroscopy-mobile-c-arms-market-7717) is projected to grow at an 8.7% compound annual growth rate (CAGR) from 2025 to 2035., driven by technological advancements and increasing demand for minimally invasive procedures. **New opportunities:** - Development of AI-driven imaging software for enhanced diagnostics. - Expansion into telemedicine solutions for remote consultations. - Partnerships with surgical centers for integrated mobile C-arm services. By 2035, the market is expected to achieve substantial growth, reflecting evolving healthcare needs. ## Segment Insights ### By Type: Fluoroscopy Systems (Largest) vs. Mobile C-Arms (Fastest-Growing) In the US fluoroscopy mobile-c-arms market, Fluoroscopy Systems currently represent the largest share, owing to their established presence and broad application across various medical procedures. These systems are preferred for their versatility and ability to provide real-time imaging, which is critical in environments such as operating rooms and diagnostics. Conversely, Mobile C-Arms are witnessing rapid adoption due to their unique mobility and ease of use, allowing for efficient imaging in diverse settings, including surgical and interventional radiology. The growth trends in this segment are significantly driven by technological advancements and the increasing demand for minimally invasive procedures. As healthcare providers seek solutions that enhance procedural efficiency and patient outcomes, the preference for mobile C-Arms is expected to surge. Innovations such as improved imaging capabilities, lower radiation exposure, and user-friendly interfaces are contributing to this segment's rapid growth, positioning it as a critical component of modern medical imaging. Fluoroscopy Systems (Dominant) vs. Mobile C-Arms (Emerging) Fluoroscopy Systems are characterized by their wide-ranging applications in various medical fields, providing dynamic imaging essential for real-time diagnosis and treatment guidance. Their dominance in the US fluoroscopy mobile-c-arms market is attributed to their reliability and proven efficacy, making them the preferred choice for many healthcare facilities. In contrast, Mobile C-Arms represent an emerging segment increasingly favored for specific applications due to their portability and ease of setup. As healthcare environments evolve to incorporate more flexible and adaptable imaging solutions, Mobile C-Arms are gaining traction. These devices are particularly valued in surgical settings where rapid access to imaging is critical, thus complementing the traditional Fluoroscopy Systems by enhancing workflow efficiency and patient care. ### By Application: Orthopedics (Largest) vs. Pain Management and Trauma (Fastest-Growing) In the US fluoroscopy mobile-c-arms market, the application segments demonstrate diverse market shares. Orthopedics leads the market due to the increasing prevalence of musculoskeletal disorders and a growing preference for minimally invasive surgical procedures. Following this segment, gastrointestinal and urology applications also share significant portions of the market, driven by consistent demand for diagnostic and therapeutic interventions. Examining growth trends, the pain management and trauma segment is emerging as the fastest-growing application area, spurred by rising incidences of orthopedic injuries and chronic pain conditions. Technological advancements such as enhanced imaging capabilities and the development of portable systems are further fueling this growth. The overall market sees robust developments, with a continuous push towards improving patient outcomes through innovative fluoroscopic solutions. Orthopedics (Dominant) vs. Pain Management and Trauma (Emerging) The orthopedics segment remains dominant in the US fluoroscopy mobile-c-arms market, characterized by its wide application in surgeries and diagnostics related to bones and joints. This segment benefits from the increased adoption of new technologies that facilitate better imaging quality and the ability to perform complex procedures with greater precision. In contrast, the pain management and trauma segment is emerging, gaining traction due to the rising need for effective pain relief solutions and treatment options for trauma patients. Innovations in mobile C-arms are enhancing the capacity to address varying clinical needs, positioning both segments as critical players in the market, with orthopedics leading while pain management is on an upward trajectory. ### By End-Users: Hospitals and Clinics (Largest) vs. Diagnostic Centers (Fastest-Growing) In the US fluoroscopy mobile-c-arms market, the distribution of market share among end-users reveals that hospitals and clinics hold the largest segment share, primarily due to their continuous demand for advanced imaging technology. They leverage these mobile C-arms for a variety of surgical procedures, leading to significant market presence. Diagnostic centers follow closely, capitalizing on the need for precise imaging in routine examinations, which supports their growth trajectory. Growth trends indicate that while hospitals and clinics continue to dominate, diagnostic centers are emerging rapidly as a significant factor in this market landscape. The increasing prevalence of chronic diseases and the need for early diagnosis drive the demand for mobile C-arms within these facilities. Additionally, technological advancements in imaging capabilities further enhance their appeal, making them a preferred choice for many diagnostic centers. Hospitals and Clinics (Dominant) vs. Diagnostic Centers (Emerging) Hospitals and clinics are characterized by their extensive use of fluoroscopy mobile-c-arms for various surgeries, including orthopedic and vascular procedures. Their established infrastructure and comprehensive patient care services position them as the dominant force in this market. On the other hand, diagnostic centers are recognized as an emerging segment, driven by the growing necessity for rapid and accurate diagnostic imaging. Their focus on outpatient services and efficiency in patient turnover allows them to adapt quickly and embrace technological advancements, further solidifying their place in the competitive landscape of the US fluoroscopy mobile-c-arms market. ## Competitive Benchmarking The fluoroscopy mobile-c-arms market exhibits a dynamic competitive landscape characterized by rapid technological advancements and a growing emphasis on patient-centric solutions. Key players such as GE Healthcare (US), Siemens Healthineers (DE), and Philips Healthcare (NL) are at the forefront, leveraging innovation and strategic partnerships to enhance their market positions. GE Healthcare (US) focuses on integrating advanced imaging technologies with artificial intelligence (AI) to improve diagnostic accuracy, while Siemens Healthineers (DE) emphasizes digital transformation and the development of hybrid operating rooms, which are increasingly popular in surgical settings. Philips Healthcare (NL) is also investing heavily in AI and data analytics to streamline workflows and enhance patient outcomes, indicating a collective shift towards technology-driven solutions in the market.The business tactics employed by these companies reflect a concerted effort to optimize operations and adapt to evolving market demands. Localizing manufacturing and optimizing supply chains are prevalent strategies aimed at reducing costs and improving responsiveness to market changes. The competitive structure of the market appears moderately fragmented, with several players vying for market share, yet the influence of major companies remains substantial, shaping industry standards and driving innovation. In September Siemens Healthineers (DE) announced a strategic partnership with a leading software company to enhance its mobile C-arm systems with advanced imaging capabilities. This collaboration is expected to significantly improve the functionality of their devices, allowing for more precise imaging during surgical procedures. Such strategic moves not only bolster Siemens' product offerings but also position the company as a leader in integrating software solutions with medical imaging technologies. In October GE Healthcare (US) launched a new mobile C-arm system that incorporates AI-driven features designed to assist surgeons in real-time decision-making. This launch underscores GE's commitment to innovation and its focus on enhancing surgical precision and patient safety. The introduction of AI capabilities is likely to attract healthcare facilities seeking to improve operational efficiency and patient outcomes, thereby strengthening GE's competitive edge in the market. In August Philips Healthcare (NL) expanded its product line by introducing a mobile C-arm specifically designed for orthopedic applications. This targeted approach not only addresses the growing demand for specialized imaging solutions but also reflects Philips' strategy to cater to niche markets within the broader healthcare landscape. By focusing on specific applications, Philips aims to differentiate itself from competitors and capture a larger share of the orthopedic imaging market. As of November the competitive trends in the fluoroscopy mobile-c-arms market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances among key players are shaping the landscape, fostering innovation and enhancing product offerings. The shift from price-based competition to a focus on technological advancement and supply chain reliability is evident, suggesting that future competitive differentiation will hinge on the ability to innovate and deliver superior solutions that meet the evolving needs of healthcare providers. ## Recent News & Developments The US Fluoroscopy Mobile C-Arms Market is witnessing significant developments, with advancements in technology and increasing demand for minimally invasive surgical procedures. Companies like Hologic and Siemens Healthineers are innovating with enhanced imaging capabilities to cater to the growing needs of healthcare institutions. In September 2023, GE Healthcare announced the launch of a new mobile C-arm designed for orthopedic surgeries, aiming to improve surgical accuracy and patient outcomes. There has also been notable interest in mergers and acquisitions; for instance, Fujifilm Holdings acquired a medical imaging firm in August 2023 to expand its fluroscopy portfolio, a move expected to enhance their market position. Current market growth is driven by an increase in outpatient procedures, evolving healthcare infrastructure, and a focus on patient-centric solutions. In light of these trends, companies like Varian Medical Systems and Canon Medical Systems are ramping up Research and Development to further solidify their presence in this lucrative market. Overall, the US Fluoroscopy Mobile C-Arms Market is experiencing dynamic changes that reflect broader trends in the healthcare industry. ## Report Scope | MARKET SIZE 2024 | 0.63(USD Million) | | --- | --- | | MARKET SIZE 2025 | 0.684(USD Million) | | MARKET SIZE 2035 | 1.58(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 8.7% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | GE Healthcare (US), Siemens Healthineers (DE), Philips Healthcare (NL), Canon Medical Systems (JP), Fujifilm Holdings (JP), Hitachi Medical Systems (JP), Hologic (US), Agfa HealthCare (BE), Esaote (IT) | | Segments Covered | Type, Application, End-Users | | Key Market Opportunities | Integration of advanced imaging technologies enhances diagnostic capabilities in the fluoroscopy mobile-c-arms market. | | Key Market Dynamics | Technological advancements drive demand for fluoroscopy mobile C-arms, enhancing surgical precision and operational efficiency. | | Countries Covered | US | ## Frequently Asked Questions **Q: What is the projected market valuation for the US fluoroscopy mobile-c-arms market in 2035?** A: The projected market valuation for the US fluoroscopy mobile-c-arms market in 2035 is expected to reach $1.58 Million. **Q: What was the market valuation for the US fluoroscopy mobile-c-arms market in 2024?** A: The market valuation for the US fluoroscopy mobile-c-arms market in 2024 was $0.63 Million. **Q: What is the expected CAGR for the US fluoroscopy mobile-c-arms market during the forecast period 2025 - 2035?** A: The expected CAGR for the US fluoroscopy mobile-c-arms market during the forecast period 2025 - 2035 is 8.7%. **Q: Which companies are considered key players in the US fluoroscopy mobile-c-arms market?** A: Key players in the US fluoroscopy mobile-c-arms market include GE Healthcare, Siemens Healthineers, Philips Healthcare, and Canon Medical Systems. **Q: What are the main application segments for the US fluoroscopy mobile-c-arms market?** A: Main application segments for the US fluoroscopy mobile-c-arms market include Orthopedics, Cardiovascular, and Pain Management and Trauma. **Q: How did the market for mobile C-arms perform in 2024?** A: In 2024, the market for mobile C-arms was valued at $0.95 Million. **Q: What is the expected growth trend for the US fluoroscopy mobile-c-arms market?** A: The US fluoroscopy mobile-c-arms market is expected to experience robust growth, potentially reaching $1.58 Million by 2035. **Q: What was the valuation of the gastrointestinal application segment in 2024?** A: The valuation of the gastrointestinal application segment in 2024 was $0.23 Million. **Q: Which end-user segment is projected to have the highest valuation in 2035?** A: The Hospital and Clinics end-user segment is projected to have the highest valuation, potentially reaching $0.62 Million in 2035. **Q: What is the valuation of the orthopedics application segment in 2024?** A: The valuation of the orthopedics application segment in 2024 was $0.30 Million. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-fluoroscopy-mobile-c-arms-market-12899*